Arkolith/Insider Trading/CTNM/Form 4

Watkins Tim

CMO & Head of DevelopmentContineum Therapeutics, Inc. (CTNM) · full profile →Form 4 · filed Mar 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$54K
Net Open-Market Flow
-$54K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)4K$4.50$16K4K
Mar 2, 2026Sell(S)4K$15.02$54K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 2, 2026Option exercise(M)4K—$0249K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-006421) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML